PURPOSE: Tobacco causes many adverse health conditions and may alter the upper gastrointestinal (UGI) microbiome. However, the few studies that studied the association between tobacco use and the microbiome were small and underpowered. Therefore, we investigated the association between tobacco use and the UGI microbiome in Chinese men. METHODS: We included 278 men who underwent esophageal cancer screening in Henan Province, China. Men were categorized as current, former, or never smokers from questionnaire data. UGI tract bacterial cells were characterized using the Human Oral Microbial Identification Microarray. Counts of unique bacterial species and genera estimated alpha diversity. For beta diversity, principal coordinate (PCoA) vectors were generated from an unweighted UniFrac distance matrix. Polytomous logistic regression models were used for most analyses. RESULTS: Of the 278 men in this study, 46.8% were current smokers and 12.6% were former smokers. Current smokers tended to have increased alpha diversity (mean 42.3 species) compared to never smokers (mean 38.9 species). For a 10 species increase, the odds ratio (OR) for current smoking was 1.29 (95% CI 1.04-1.62). Beta diversity was also associated with current smoking. The first two PCoA vectors were strongly associated with current smoking (PCoA1 OR 0.66; 95% CI 0.51-0.87; PCoA2 OR 0.73; 95% CI 0.56-0.95). Furthermore, Dialister invisus and Megasphaera micronuciformis were more commonly detected in current smokers than in never smokers. CONCLUSIONS: Current smoking was associated with both alpha and beta diversity in the UGI tract. Future work should consider how the UGI microbiome is associated with smoking-related diseases.
PURPOSE:Tobacco causes many adverse health conditions and may alter the upper gastrointestinal (UGI) microbiome. However, the few studies that studied the association between tobacco use and the microbiome were small and underpowered. Therefore, we investigated the association between tobacco use and the UGI microbiome in Chinese men. METHODS: We included 278 men who underwent esophageal cancer screening in Henan Province, China. Men were categorized as current, former, or never smokers from questionnaire data. UGI tract bacterial cells were characterized using the Human Oral Microbial Identification Microarray. Counts of unique bacterial species and genera estimated alpha diversity. For beta diversity, principal coordinate (PCoA) vectors were generated from an unweighted UniFrac distance matrix. Polytomous logistic regression models were used for most analyses. RESULTS: Of the 278 men in this study, 46.8% were current smokers and 12.6% were former smokers. Current smokers tended to have increased alpha diversity (mean 42.3 species) compared to never smokers (mean 38.9 species). For a 10 species increase, the odds ratio (OR) for current smoking was 1.29 (95% CI 1.04-1.62). Beta diversity was also associated with current smoking. The first two PCoA vectors were strongly associated with current smoking (PCoA1 OR 0.66; 95% CI 0.51-0.87; PCoA2 OR 0.73; 95% CI 0.56-0.95). Furthermore, Dialister invisus and Megasphaera micronuciformis were more commonly detected in current smokers than in never smokers. CONCLUSIONS: Current smoking was associated with both alpha and beta diversity in the UGI tract. Future work should consider how the UGI microbiome is associated with smoking-related diseases.
Authors: Floyd E Dewhirst; Tuste Chen; Jacques Izard; Bruce J Paster; Anne C R Tanner; Wen-Han Yu; Abirami Lakshmanan; William G Wade Journal: J Bacteriol Date: 2010-07-23 Impact factor: 3.490
Authors: Qin-Jing Pan; Mark J Roth; Hui-Qin Guo; Michael L Kochman; Guo-Qing Wang; Michael Henry; Wen-Qiang Wei; Carol A Giffen; Ning Lu; Christian C Abnet; Chang-Qing Hao; Philip R Taylor; You-Lin Qiao; Sanford M Dawsey Journal: Acta Cytol Date: 2008 Jan-Feb Impact factor: 2.319
Authors: Lee D Chaves; Daniel I McSkimming; Mark A Bryniarski; Amanda M Honan; Sham Abyad; Shruthi A Thomas; Steven Wells; Michael Buck; Yijun Sun; Robert J Genco; Richard J Quigg; Rabi Yacoub Journal: Am J Physiol Renal Physiol Date: 2018-04-25
Authors: Sara H Olson; Jaya Satagopan; Youming Xu; Lilan Ling; Siok Leong; Irene Orlow; Amethyst Saldia; Peter Li; Pamela Nunes; Vincent Madonia; Peter J Allen; Eileen O'Reilly; Eric Pamer; Robert C Kurtz Journal: Cancer Causes Control Date: 2017-07-31 Impact factor: 2.506
Authors: William Massey; Lucas J Osborn; Rakhee Banerjee; Anthony Horak; Kevin K Fung; Danny Orabi; E Ricky Chan; Naseer Sangwan; Zeneng Wang; J Mark Brown Journal: Metabolites Date: 2022-04-18
Authors: Sierra Simpson; Rio Mclellan; Emma Wellmeyer; Frederic Matalon; Olivier George Journal: J Neuroimmune Pharmacol Date: 2021-10-25 Impact factor: 7.285
Authors: Jason E Martinez; Doron D Kahana; Simran Ghuman; Haley P Wilson; Julian Wilson; Samuel C J Kim; Venu Lagishetty; Jonathan P Jacobs; Amiya P Sinha-Hikim; Theodore C Friedman Journal: Front Endocrinol (Lausanne) Date: 2021-06-08 Impact factor: 5.555